Anebulo Pharmaceuticals Inc (ANEB)
2.73
+0.10
(+3.80%)
USD |
NASDAQ |
Jun 28, 16:00
Anebulo Pharmaceuticals 1 Year Total Returns (Daily): 19.21% for June 28, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 28, 2024 | 19.21% |
| June 27, 2024 | 18.47% |
| June 26, 2024 | 36.06% |
| June 25, 2024 | 28.42% |
| June 24, 2024 | 21.08% |
| June 21, 2024 | 24.67% |
| June 20, 2024 | -12.04% |
| June 18, 2024 | -9.74% |
| June 17, 2024 | -10.57% |
| June 14, 2024 | -8.70% |
| June 13, 2024 | -10.64% |
| June 12, 2024 | -15.08% |
| June 11, 2024 | -23.77% |
| June 10, 2024 | -24.53% |
| June 07, 2024 | -10.40% |
| June 06, 2024 | -12.94% |
| June 05, 2024 | -19.68% |
| June 04, 2024 | -15.54% |
| June 03, 2024 | -14.74% |
| May 31, 2024 | -7.08% |
| May 30, 2024 | -11.76% |
| May 29, 2024 | -13.87% |
| May 28, 2024 | -12.60% |
| May 24, 2024 | -16.40% |
| May 23, 2024 | -8.64% |
| Date | Value |
|---|---|
| May 22, 2024 | -7.08% |
| May 21, 2024 | 2.43% |
| May 20, 2024 | 4.37% |
| May 17, 2024 | -0.87% |
| May 16, 2024 | -4.95% |
| May 15, 2024 | 1.51% |
| May 14, 2024 | -1.94% |
| May 13, 2024 | 3.66% |
| May 10, 2024 | 30.87% |
| May 09, 2024 | 30.43% |
| May 08, 2024 | 31.03% |
| May 07, 2024 | 25.10% |
| May 06, 2024 | 21.39% |
| May 03, 2024 | 27.71% |
| May 02, 2024 | 38.67% |
| May 01, 2024 | 18.40% |
| April 30, 2024 | -0.68% |
| April 29, 2024 | -5.82% |
| April 26, 2024 | -3.44% |
| April 25, 2024 | -0.20% |
| April 24, 2024 | 0.71% |
| April 23, 2024 | -3.21% |
| April 22, 2024 | -4.29% |
| April 19, 2024 | -6.08% |
| April 18, 2024 | -3.72% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-74.10%
Minimum
Oct 20 2022
48.88%
Maximum
Oct 23 2023
-31.61%
Average
-32.15%
Median
May 09 2023
1 Year Total Returns (Daily) Benchmarks
| NovaBay Pharmaceuticals Inc | -91.58% |
| Palatin Technologies Inc | -8.02% |
| iBio Inc | -82.12% |
| Theriva Biologics Inc | -75.13% |
| Oragenics Inc | -69.32% |